CoChat

Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF‐7 cells

Proietti, Sara, Cucina, Alessandra, Dobrowolny, Gabriella, D'Anselmi, Fabrizio, Dinicola, Simona, Masiello, Maria Grazia, Pasqualato, Alessia, Palombo, Alessandro, Morini, Veronica, Reiter, Russel J., Bizzarri, Mariano · 2014 · Journal of Pineal Research
Cited by 96

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Compelling evidence demonstrated that melatonin increases p53 activity in cancer cells. p53 undergoes acetylation to be stabilized and activated for driving cells destined for apoptosis/growth inhibition. Over‐expression of p300 induces p53 acetylation, leading to cell growth arrest by increasing p21 expression. In turn, p53 activation is mainly regulated in the nucleus by MDM 2. MDM 2 also acts as E3 ubiquitin ligase, promoting the proteasome‐dependent p53 degradation. MDM 2 entry into the nucleus is finely tuned by two different modulations: the ribosomal protein L11, acts by sequestering MDM 2 in the cytosol, whereas the PI 3K‐AkT‐dependent MDM 2 phosphorylation is mandatory for MDM 2 translocation across the nuclear membrane. In addition, MDM 2‐dependent targeting of p53 is regulated in a nonlinear fashion by MDM 2/MDMX interplay. Melatonin induces both cell growth inhibition and apoptosis in MCF 7 breast cancer cells. We previously reported that this effect is associated with reduced MDM 2 levels and increased p53 activity. Herein, we demonstrated that melatonin drastically down‐regulates MDM 2 gene expression and inhibits MDM 2 shuttling into the nucleus, given that melatonin increases L11 and inhibits Akt‐PI 3K‐dependent MDM 2 phosphorylation. Melatonin induces a 3‐fold increase in both MDMX and p300 levels, decreasing simultaneously Sirt1, a specific inhibitor of p300 activity. Consequently, melatonin‐treated cells display significantly higher values of both p53 and acetylated p53. Thus, a 15‐fold increase in p21 levels was observed in melatonin‐treated cancer cells. Our results provide evidence that melatonin enhances p53 acetylation by modulating the MDM 2/MDMX/p300 pathway, disclosing new insights for understanding its anticancer effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jpi.12150

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 96

Metadata

Authors
Proietti, S., Cucina, A., Dobrowolny, G., D'Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., & Bizzarri, M.
Venue
Journal of Pineal Research
Publisher
Wiley
Published
2014-07-10
Volume
57
Issue
1
Pages
120-129
ISSN
  • 0742-3098 (ISSN-L)
  • 1600-079X
OpenAlex
W2136429046
Cited by
96
References
16
FWCI
5.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.